Massachusetts General Hospital
165 Cambridge Street, Suite 301
Boston,
MA
02114
Phone: 877-644-2860
Fax: 617-724-8652
Hours: Monday - Friday, 8:00 am - 4:00 pm
A pioneer in organ transplant since 1963, the Kidney Transplant Program at the Massachusetts General Hospital Transplant Center employs leading-edge medical and surgical technology to provide individualized care for patients with chronic kidney disease. Our expert surgeons have performed more than 3,000 kidney transplants and have achieved some of the best graft and patient survival rates in the country. In 2017, 40% of patients receiving kidney transplants at Mass General never needed a single dialysis treatment prior to transplant, which is more than twice the national average.
Learn about our programs:
Kidney transplant patients typically require lifelong immunosuppressive medications to prevent their immune systems from attacking the new organ. However, our ground-breaking research is allowing some patients to live drug-free after transplant. We also offer options for highly sensitized patients, patients with incompatible living donors and patients with challenging medical or surgical issues.
We have consistently led the field in tolerance or the acceptance of transplanted organs without long-term immunosuppression. We performed the first successful tolerance induction for renal allografts in patients with multiple myeloma in 1998. We initiated the first ITN-sponsored clinical tolerance trials for adults in 2001 and performed the first successful tolerance induction in mismatched renal transplant recipients in 2008.
All our patients receive integrated, comprehensive care to treat chronic renal failure, beginning with a careful assessment and discussion with the patient to ensure that transplantation is his/her best treatment option. Candidates work with a transplant coordinator, who participates in the initial evaluation, gathers medical information and previous test results. The transplant coordinator also manages the patient’s full evaluation, which includes:
To begin the kidney transplant process, you must first be referred to the Mass General Kidney Transplant Clinic by your primary care physician or nephrologist. A kidney transplant nurse coordinator along with a transplant nephrologist will review your referral and medical records once they have been received. Transplant Center staff will then schedule an initial evaluation appointment. If you are also a candidate for pancreas transplantation, you will be evaluated for both transplants at the same time.
Depending on the number of tests required for each patient, the length of the evaluation process can vary, but our goal is to complete all testing within four months. The Mass General Kidney Transplant Program also conducts a monthly evaluation clinic at four locations throughout New England. Please ask your patient service coordinator for more information on scheduling an appointment at one of these convenient locations.
You will begin the kidney transplant evaluation at the scheduled Multidisciplinary Kidney Transplant Evaluation Clinic held on Tuesdays, Thursdays and Fridays. During the day you will:
After the initial clinic visit you will return for additional testing and appointments as needed. The kidney transplant team will assist you in scheduling these tests and appointments, which may include:
You will be responsible for scheduling the following tests with your primary care physician and/or providing recent results in order to complete the transplant evaluation:
Kidney transplant candidates are placed on the national United Network for Organ Sharing (UNOS) waiting list, which manages the distribution of organs nationwide.
Once testing is complete, the entire transplant team will meet to determine your candidacy to be listed for a kidney transplant. You and your referring physician and dialysis center, if applicable, will be informed of the committee’s decision.
Prior to your transplant evaluation, please download and complete the evaluation consent form. You can submit your completed form to your transplant care team via Patient Gateway.
Download the evaluation consent form
If you are found to be a good candidate for kidney transplantation, the best option is to undergo transplant with a living donor, as this does not require time on the waiting list. Patients without a living donor wait on the list for a deceased donor kidney. Because there are many more people who need a kidney transplant than there are kidneys available, a waiting list is managed by the United Network for Organ Sharing (UNOS). UNOS gives priority to patients based on waiting time and over a time period of years patients move to the top of the list, and receive a kidney.
When a deceased donor organ is available, you will receive a call from our coordinator or surgeon, asking you to come into the hospital for the transplant. Since this call can come at any time during the day or night, any day of the week, it is important for the transplant team to be able to reach you. You should provide our center with all of your phone numbers, as well as the phone numbers of a few emergency contacts, so that we can contact you when needed.
Mass General is a leader in transplanting patients whose live donor is incompatible with them, either because of blood group or anti-HLA antibodies. We offer:
The Mass General living donor team hosts an ongoing virtual education series called “How to Find a Living Kidney Donor,” that aims to equip kidney recipients and their loved ones with the necessary knowledge, support and tools to find a living donor. The dates alternate on the fourth Monday and Thursday of every month.
Register for an upcoming event
Mass General performs significantly more kidney transplants than other Massachusetts institutions. Higher volumes mean more experience.
Our high volume of kidney transplants — and skilled team of kidney transplant surgeons, anesthesiologists, nurses and social workers who guide patients through every stage of care — help us to attain excellent results in treating patients who need a kidney transplant.
Data Source: United Network for Organ Sharing (UNOS)
Data Period: January 2019-December 2020
The Mass General Kidney Transplant team guides patients through every stage of care with a multidisciplinary team of doctors, nurses, case managers, financial coordinators and other clinicians to help navigate the transplant process.
Patients share their experiences receiving care at the Mass General Transplant Center.
Download the below PDFs for additional information about kidney transplantation at Mass General.
Download this PDF to learn about how to prepare for kidney transplant at Mass General.
Download this PDF to learn about what to expect following the donation of your kidney.
Complete this form prior to evaluation & send to your transplant team via Patient Gateway.
Transplant patients take medications to keep their immune system from rejecting their new organs. The standard medications used today are effective but have many side effects, including toxicity to the transplanted kidney which tends to shorten the lifespan of the organ. Less toxic drugs have been developed to support better long-term kidney function. The MGH Transplant Center is one of many academic medical centers conducting clinical trials using these newer immunosuppressive agents.
In spite of advances over the last 50 years in anti-rejection medications, the side effects of long-term immunosuppressive therapy remain a major problem for post-transplant patients. The MGH Transplant Center has been a leader in developing procedures that allow transplant patients to take fewer or no medications. These protocols continue to improve in living donor kidney transplantation and will soon expand to include patients who receive deceased donor kidneys as well.
The absence of insulin-producing cells in the body results in type 1 diabetes. Islet transplantation replaces the insulin-producing cells of the pancreas without the risks of major abdominal surgery that come with a whole organ pancreas transplant. The MGH Transplant Center is one of the few centers in the country, and the only in New England, that can isolate and transplant pancreatic islets. Islet transplantation is an option for patients who have had a previous kidney transplant and for those without kidney disease.
Infections after transplant are relatively common, especially within the first year. All transplant patients receive prophylactic therapy in order to prevent such infections. The MGH Transplant Center is participating in clinical trials which utilize different medications and monitoring of infections in order to prevent and treat post-transplant infections.
Until 2015, transplanting organs from HIV positive donors was not allowed under the National Organ Transplant Act of 1984. However, since HIV treatments have improved and HIV positive transplant recipients have done well after transplant, the HIV Organ Policy Equity (HOPE) Act was recently passed.
The HOPE Act allows organs from HIV positive donors to be transplanted into HIV positive recipients. These are organs that would have been discarded before the HOPE Act was passed. The MGH Transplant Center is one of the few hospitals in the United States doing these transplants.
Currently there are more available hepatitis C positive deceased donors in New England than there are recipients. With the arrival of new anti-viral agents Hepatitis C cure rates are almost at 100%. Under a clinical trial protocol we are now transplanting kidneys from donors who are positive for hepatitis C virus into select recipients who are not infected with the hepatitis C virus. Patients who enter into this trial receive immediate pre-emptive treatment for Hepatitis C. This will allow these selected recipients to be receive a transplant more quickly, avoiding many consequences of prolonged time on the waitlist and dialysis related complications.
The Kidney Transplant Program at Massachusetts General Hospital provides individualized, ongoing care for patients with end-stage renal disease (kidney failure).
